A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.

PHASE2CompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

August 31, 2005

Conditions
Rheumatoid Arthritis
Interventions
DRUG

AD 452

Trial Locations (10)

19090

Rheumatic Disease Associates, Willow Grove

21045

Dept of Rheumatology, Columbia Medical Practice, Columbia

33334

Center for Rheumatology, Immunology and Arthritis, Fort Lauderdale

33703

Advent Clinical Research Centers, Inc., St. Petersburg

33765

Clinical Research of West Florida, Inc, Clearwater

34239

Sarasota Arthritis Research Center, Sarasota

34474

Ocala Rheumatology Research Center, Ocala

08817

Anderson and Collins Clinical Research, Inc., Edison

08035

Station Avenue, Haddon Heights

08755

Atlantic Coast Research LLC, Toms River

All Listed Sponsors
lead

Sosei

INDUSTRY

NCT00141934 - A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects. | Biotech Hunter | Biotech Hunter